OOIR: Observatory of International Research

Papers

(The H4-Index of Advanced Drug Delivery Reviews is 79. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Integrating microneedles and sensing strategies for diagnostic and monitoring applications: The state of the art	456
Long-acting inhaled medicines: Present and future	408
Editorial Board	322
Editorial board members	270
Editorial board members	262
Editorial: Ocular drug delivery – Challenges, opportunities, and developments	229
Spectroscopic techniques for monitoring stem cell and organoid proliferation in 3D environments for therapeutic development	223
Advanced vaccine delivery	220
Editorial board members	204
Special Issue (SI) on: Emerging pharmaceutical technologies (From advanced materials & formulations to new processes) for novel dosage development	195
Editorial board members	185
Trends in versatile 2D (sheet/paper-like) nanomaterials for biomedical applications	184
Recent advances in endocrine organoids for therapeutic application	179
Preface: Phyto-derived nanomedicines for therapeutics, imaging and drug delivery	179
Agony of choice: How anesthetics affect the composition and function of extracellular vesicles	176
Editorial board members	171
Current and prospective computational approaches and challenges for developing COVID-19 vaccines	169
Principles and applications of sono-optogenetics	164
Oral drug delivery strategies for development of poorly water soluble drugs in paediatric patient population	160
The tendon microenvironment: Engineered in vitro models to study cellular crosstalk	159
2D materials-based nanomedicine: From discovery to applications	155
Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages	152
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics	151
Models to study basic and applied aspects of lysosomal storage disorders	150
Nanovaccines with cell-derived components for cancer immunotherapy	145

Molecular imaging of innate immunity and immunotherapy	144
Emerging plasmonic nanoparticles and their assemblies for cancer radiotherapy	142
Harnessing artificial intelligence for the next generation of 3D printed medicines	140
The role of coagulome in the tumor immune microenvironment	137
Sensing technologies and experimental platforms for the characterization of advanced oral drug delivery systems	133
Brain metastasis models: What should we aim to achieve better treatments?	130
Mastering the Gram-negative bacterial barrier – Chemical approaches to increase bacterial bioavailability of antibiotics	123
Biologics and their delivery systems: Trends in myocardial infarction	120
The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis	119
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria	118
Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome	117
Progress of tumor-resident intracellular bacteria for cancer therapy	114
Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties	109
Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe	109
Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors – An update	106
Recent applications of electrical, centrifugal, and pressurised emerging technologies for fibrous structure engineering in drug delivery, regenerative medicine and theranostics	105
Nanoparticle-neutrophils interactions for autoimmune regulation	104
Penetration and translocation of functional inorganic nanomaterials into biological barriers	102
Therapeutic and delivery strategies of phytoconstituents for renal fibrosis	101
Demystifying phytoconstituent-derived nanomedicines in their immunoregulatory and therapeutic roles in inflammatory diseases	100
Cell and biomaterial delivery strategies to induce immune tolerance	100
Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design	99
Laser ablation: Heating up the anti-tumor response in the intracranial compartment	97
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses	97
Bioequivalence assessment of pharmaceutical aerosol products through IVIVC	97
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles	96
Artificial intelligence to bring nanomedicine to life	95
Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants	95
Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?	95
Microneedle-Mediated Vaccination: Innovation and Translation	95
Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment	95
Non-spherical micro- and nanoparticles for drug delivery: Progress over 15 years	94
Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers	94
Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms	92
Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies	91
Supramolecular engineering of hydrogels for drug delivery	91
Ocular therapies with biomacromolecules: From local injection to eyedrop and emerging noninvasive delivery strategies	90
Polysaccharide hydrogel platforms as suitable carriers of liposomes and extracellular vesicles for dermal applications	89
Microbubble-assisted ultrasound for inner ear drug delivery	87
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function	86
Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases	86
Leveraging the neurosurgical operating room for therapeutic development in NeuroOncology	86
Advances in bacteria-based therapy for drug delivery	84
Protein-engineered biomaterials for cartilage therapeutics and repair	84
Nanomedicine to fight infectious disease	82
Emerging antibiotic alternatives: From antimicrobial peptides to bacteriophage therapies	82
Application of colloidal photonic crystals in study of organoids	82
Transflammation in tissue regeneration and response to injury: How cell-autonomous inflammatory signaling mediates cell plasticity	81
Merging data curation and machine learning to improve nanomedicines	81
Liposomal formulations for treating lysosomal storage disorders	81

Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity	81
Regulation of in vivo delivery of nanomedicines by herbal medicines	81
Using bugs as drugs: Administration of bacteria-related microbes to fight cancer	80
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound	80
Development of nucleic acid medicines based on chemical technology	79